Issue Date | Title | Author(s) |
2019-03-01 | Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data | Holleman, MS; Uyl-de Groot, CA; Goodall, S; van der Linden, N |
2008-01 | Quality of life and survival in the 2 years after surgery for non-small cell lung cancer | Kenny, PM; King, MT; Viney, RC; Boyer, M; Pollicino, C; McLean, J; Fulham, MJ; McCaughn, B |
2012-11-22 | Chemotherapy administration: Modelling the costs of alternative protocols | Haywood, P; De Raad, J; Van Gool, K; Haas, M; Gallego, G; Pearson, SA; Faedo, M; Ward, R |
2017-09-01 | Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands | van der Linden, N; Bongers, ML; Coupé, VMH; Smit, EF; Groen, HJM; Welling, A; Schramel, FMNH; Uyl-de Groot, CA |
2016-01-01 | Costs of non-small cell lung cancer in the Netherlands | van der Linden, N; Bongers, ML; Coupé, VMH; Smit, EF; Groen, HJM; Welling, A; Schramel, FMNH; Uyl-de Groot, CA |
2004-12-01 | Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer | Viney, RC; Boyer, MJ; King, MT; Kenny, PM; Pollicino, CA; McLean, JM; McCaughan, BC; Fulham, MJ |
2015-01-01 | Protocol for the CHEST Australia trial: A phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancer | Murray, SR; Murchie, P; Campbell, N; Walter, FM; Mazza, D; Habgood, E; Kutzer, Y; Martin, A; Goodall, S; Barnes, DJ; Emery, JD |
2017-10-01 | Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study | Pearce, A; Haas, M; Viney, R; Pearson, SA; Haywood, P; Brown, C; Ward, R |
2016-12-02 | Urban-rural differences in cancer-directed surgery and survival of patients with non-small cell lung cancer | Thomas, AA; Pearce, A; O'neill, C; Molcho, M; Sharp, L |
2016-03-04 | A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II) | Siva, S; Kron, T; Bressel, M; Haas, M; Mai, T; Vinod, S; Sasso, G; Wong, W; Le, H; Eade, T; Hardcastle, N; Chesson, B; Pham, D; Høyer, M; Montgomery, R; Ball, D |